References
1. Bellentani S, Bedogni G, Miglioli L, Tiribelli C. The epidemiology of fatty liver. European journal of gastroenterology & hepatology 2004;16(11):1087–1093.
2. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. The American journal of medicine 1999;107(5):450–455.
3. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55(6):2005–2023.
4. Anstee QM, Day CP. The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2. In Seminars in liver disease 2015;35(3):270–290.
5. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Alimentary pharmacology & therapeutics 2007;25(8):883–889.
6. Ministry of Food and Drug Safety. Influence of dietary intake on non-alcoholic fatty liver disease in Koean Cheongwon, Korea: Ministry of Food and Drug Safety; 2012.
7. Jang E, Shin MH, Kim KS, Kim Y, Na YC, Woo HJ. Anti-lipoapoptotic effect of Artemisia capillaris extract on free fatty acids-induced HepG2 cells. BMC complementary and alternative medicine 2014;14(1):253.
8. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. Journal of Clinical Investigation 2004;114(2):147.
9. Park SH. Nonalcoholic fatty liver disease: treatment. Korean Journal of Medicine 2010;79(5):481–489.
10. Han CW, Lee JH. Effects of KHchunggan -tang on the nonalcoholic fatty liver disease in palmitate-induced cellular model. J Korean Oriental Med 2011;32(1):109–110.
11. Kim SY, Kwon JN, Lee I, Hong JW, Choi JY, Park SH, et al. Research on Anti-lipogenic Effect and Underlying Mechanism of Laminaria japonica on Experimental Cellular Model of Non-alcoholic Fatty Liver Disease. The Journal of Korean Oriental Internal Medicine 2014;35(2):175–183.
12. Choi MY, Woo HJ, Kim YC, Lee JH. Effects of Gamisaenggan-tang on High Fat Diet-induced Nonalcoholic Fatty Liver Disease. Korean J. Orient. Int. Med 2009;30(2):365–374.
13. Lee JY, Yoon BK. Effects of Samhwangsasim -tang on obesity-related metabolic diseaseinmice. Dept. of Korean Medicine 2014;22(1):93–104.
14. Yoon HJ, Park YS. Effects of Scutellariabaicalensis water extract on lipid metabolism and antioxidant defense system in rats fed high fat diet. Journal of The Korean Society of Food Science and Nutrition 2010;
15. Ro HS, Ko WK, Kim OJ, Park KK, Cho YW, Park HS. Antihyperlipidemic Activity of Scutellarisbaicalensis Georg., Coptidis japonica Makino and RheikoreanumNakai on Experimental Hyperlipidemia in Rats. Journal of Pharmaceutical Investigation 1996;26(3):215–219.
16. Choi SE, Jung IR, Lee YJ, Lee SJ, Lee JH, Kim Y, et al. Stimulation of lipogenesis as well as fatty acid oxidation protects against palmitate-induced INS-1 β-cell death. Endocrinology 2011;152(3):816–827.
17. Ramirez-Zacarias JL, Castro-Munozledo F, Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil Red O. Histochemistry 1992;97(6):493–497.
18. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. Journal of Biological Chemistry 2004;279(31):32345–32353.
19. Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. Journal of gastroenterology and hepatology 2006;21(1):138–143.
20. Marra F, Gastaldelli A, Baroni GS, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends in molecular medicine 2008;14(2):72–81.
21. Wahren J, Sato Y, Ostman J, Hagenfeldt L, Felig P. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise. Journal of Clinical Investigation 1984;73(5):1367.
22. Chen G, Liang G, Ou J, Goldstein JL, Brown MS. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proceedings of the National Academy of Sciences of the United States of America 2004;101(31):11245–11250.
23. Chung MH, Han SJ. Effect of composite preparation of crude drugs on experimentally induced hyperlipemia in rats-Sam WhangSasim Tang and Whang Ryun Haedok Tang. Korean Journal of Pharmacognosy (Korea Republic) 1996;7(2):46–54.
24. Oh MG, Song YS. Influence of RhizomaRhei water extract on the obese mouse model. J Oriental Rehab Med 1997;7(2):46–54.
25. Oltval ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. cell 1993;74(4):609–619.
26. Tamm I, Wang Y, Sausville ED, Scudiero DA, Vigna N, Oltersdorf T, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer research 1998;58(23):5315–5320.
27. Levkau B, Koyama H, Raines EW, Clurman B E, Herren B, Orth K, et al. Cleavage of p21 Cip1/Waf1 and p27 Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Molecular cell 1998;1(4):553–563.
28. Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell death and differentiation 1996;6(2):99–104.
29. Petruschke TH, Röhrig K, Hauner H. Transforming growth factor beta (TGF-beta) inhibits the differentiation of human adipocyte precursor cells in primary culture. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity 1994;18(8):532–536.
30. Nam IK, Yoo J. Downregulation of SGK1 Expression is Critical for TGF-β-induced Apoptosis in Mouse Hepatocytes Cells. Journal of life science 2012;22(11):1500–1506.
31. Cha JY, Repa JJ. The liver X receptor (LXR) and hepatic lipogenesis The carbohydrate-response element-binding protein is a target gene of LXR. Journal of Biological Chemistry 2007;282(1):743–751.
32. Berlanga A, Guiu-Jurado E, Porras JA, Auguet T. Molecular pathways in non-alcoholic fatty liver disease. Clinical and experimental gastroenterology 2014;7:221.
33. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JMA, Shimomura I. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes & development 2000;14(22):2819–2830.